Данный обзор литературы посвящён анализу современных представлений об офтальмологических проявлениях по данным зарубежной научной литературы в системе PubMed за 2017–2020 гг. при наиболее часто встречающихся ревматических заболеваниях (ревматоидном артрите, анкилозирующем спондилите, системной красной волчанке, системной склеродермии, системных васкулитах), которые характеризуются поражением всех структур глаза и его придаточного аппарата: век, тканей глазницы, оболочек глазного яблока, сосудов, зрительного нерва и стекловидного тела. Поражение глаз может быть дебютом, одним из диагностических признаков либо биомаркером фонового заболевания.

rheumatic diseasesophthalmological manifestationsbiomarkerревматические заболеванияофтальмологические проявлениябиомаркер1.Pathak S, McDermott MF, Savic S. Autoinflammatory diseases: update on classification diagnosis and management. J Clin Pathol. 2017;70(1):1–8. DOI: 10.1136/jclinpath-2016-203810Pathak S., McDermott M.F., Savic S. Autoinflammatory diseases: update on classification diagnosis and management // J Clin Pathol. 2017. Vol. 70, No. 1. P. 1–8. DOI: 10.1136/jclinpath-2016-2038102.Nayak K, Misra M. A review on recent drug delivery systems for posterior segment of eye. Biomed Pharmacother. 2018;107: 1564–1582. DOI: 10.1016/j.biopha.2018.08.138Nayak K., Misra M. A review on recent drug delivery systems for posterior segment of eye // Biomed Pharmacother. 2018. Vol. 107. P. 1564–1582. DOI: 10.1016/j.biopha.2018.08.1383.Kemeny-Beke A, Szodoray P. Ocular manifestations of rheumatic diseases. Int Ophthalmol. 2020;40(2):503–510. DOI: 10.1007/s10792-019-01183-9Kemeny-Beke A., Szodoray P. Ocular manifestations of rheumatic diseases // Int Ophthalmol. 2020. Vol. 40, No. 2. P. 503–510. DOI: 10.1007/s10792-019-01183-94.Kötter I., Stübiger N., Deuter C. Ocular involvement in rheumatoid arthritis, connective tissue diseases and vasculitis. Z Rheumatol. 2017;76(8):673–681. DOI: 10.1007/s00393-017-0372-7 (In Ger.)Kötter I., Stübiger N., Deuter C. Augenbeteiligung bei rheumatoider Arthritis, Kollagenosen und Vaskulitiden // Z Rheumatol. 2017. Vol. 76, No. 8. P. 673–681. DOI: 10.1007/s00393-017-0372-75.Caimmi C, Crowson CS, Smith WM, et al. Clinical Correlates, Outcomes, and Predictors of Inflammatory Ocular Disease Associated with Rheumatoid Arthritis in the Biologic Era. J Rheumatol. 2018;45(5):595–603. DOI: 10.3899/jrheum.170437Caimmi C., Crowson C.S., Smith W.M., et al. Clinical Correlates, Outcomes, and Predictors of Inflammatory Ocular Disease Associated with Rheumatoid Arthritis in the Biologic Era // J Rheumatol. 2018. Vol. 45, No. 5. P. 595–603. DOI: 10.3899/jrheum.1704376.Abd-Allah NM, Hassan AA, Omar G, et al. Dry eye in rheumatoid arthritis: relation to disease activity. Immunol Med. 2020;43(2): 92–97. DOI: 10.1080/25785826.2020.1729597Abd-Allah N.M., Hassan A.A., Omar G., et al. Dry eye in rheumatoid arthritis: relation to disease activity // Immunol Med. 2020. Vol. 43, No. 2. P. 92–97. DOI: 10.1080/25785826.2020.17295977.Rentka A, Nagy A, Harsfalvi J, et al. Association between objective signs and subjective symptoms of dry eye disease in patients with systemic sclerosis. Rheumatol Int. 2017;37(11):1835–1845. DOI: 10.1007/s00296-017-3794-2Rentka A., Nagy A., Harsfalvi J., et al. Association between objective signs and subjective symptoms of dry eye disease in patients with systemic sclerosis // Rheumatol Int. 2017. Vol. 37, No. 11. P. 1835–1845. DOI: 10.1007/s00296-017-3794-28.Rassi DM, De Paiva CS, Dias LC, et al. Review: MicroRNAS in ocular surface and dry eye diseases. Ocul Surf. 2017;15(4):660–669. DOI: 10.1016/j.jtos.2017.05.007Rassi D.M., De Paiva C.S., Dias L.C., et al. Review: MicroRNAS in ocular surface and dry eye diseases // Ocul Surf. 2017. Vol. 15, No. 4. P. 660–669. DOI: 10.1016/j.jtos.2017.05.0079.Kuklinski E, Asbell PA. Sjogren’s syndrome from the perspective of ophthalmology. Clin Immunol. 2017;182:55–61. DOI: 10.1016/j.clim.2017.04.017Kuklinski E., Asbell P.A. Sjogren’s syndrome from the perspective of ophthalmology // Clin Immunol. 2017. Vol. 182. P. 55–61. DOI: 10.1016/j.clim.2017.04.01710.Şahin M, Yüksel H, Şahin A, et al. Evaluation of the Anterior Segment Parameters of the Patients with Scleroderma. Ocul Immunol Inflamm. 2017;25(2):233–238. DOI: 10.3109/09273948.2015.1115079Şahin M., Yüksel H., Şahin A., et al. Evaluation of the Anterior Segment Parameters of the Patients with Scleroderma // Ocul Immunol Inflamm. 2017. Vol. 25, No. 2. P. 233–238. DOI: 10.3109/09273948.2015.111507911.Mayali H, Altinisik M, Sencan S, et al. A multimodal ophthalmic analysis in patients with systemic sclerosis using ocular response analyzer, corneal topography and specular microscopy. Int Ophthalmol. 2020;40(2):287–296. DOI: 10.1007/s10792-019-01173-xMayali H., Altinisik M., Sencan S., et al. A multimodal ophthalmic analysis in patients with systemic sclerosis using ocular response analyzer, corneal topography and specular microscopy // Int Ophthalmol. 2020. Vol. 40, No. 2. P. 287–296. DOI: 10.1007/s10792-019-01173-x12.Cao Y, Zhang W, Wu J, et al. Peripheral Ulcerative Keratitis Associated with Autoimmune Disease: Pathogenesis and Treatment. J Ophthalmol. 2017;2017:7298026. DOI: 10.1155/2017/7298026Cao Y., Zhang W., Wu J., et al. Peripheral Ulcerative Keratitis Associated with Autoimmune Disease: Pathogenesis and Treatment // J Ophthalmol. 2017. Vol. 2017. P. 7298026. DOI: 10.1155/2017/729802613.Watanabe R, Ishii T, Yoshida M, et al. Ulcerative keratitis in patients with rheumatoid arthritis in the modern biologic era: a series of eight cases and literature review. Int J Rheum Dis. 2017;20(2):225–230. DOI: 10.1111/1756-185X.12688Watanabe R., Ishii T., Yoshida M., et al. Ulcerative keratitis in patients with rheumatoid arthritis in the modern biologic era: a series of eight cases and literature review // Int J Rheum Dis. 2017. Vol. 20, No. 2. P. 225–230. DOI: 10.1111/1756-185X.1268814.Timlin HM, Hall HN, Foot B, Koay P. Corneal perforation from peripheral ulcerative keratopathy in patients with rheumatoid arthritis: epidemiological findings of the British Ophthalmological Surveillance Unit. Br J Ophthalmol. 2018;102(9):1298–1302. DOI: 10.1136/bjophthalmol-2017-310671Timlin H.M., Hall H.N., Foot B., Koay P. Corneal perforation from peripheral ulcerative keratopathy in patients with rheumatoid arthritis: epidemiological findings of the British Ophthalmological Surveillance Unit // Br J Ophthalmol. 2018. Vol. 102, No. 9. P. 1298–1302. DOI: 10.1136/bjophthalmol-2017-31067115.Héron E, Bourcier T. Scleritis and episcleritis. J Fr Ophtalmol. 2017;40(8):681–695. DOI: 10.1016/j.jfo.2017.04.007Héron E., Bourcier T. Sclérites et épisclérites // J Fr Ophtalmol. 2017. Vol. 40, No. 8. P. 681–695. DOI: 10.1016/j.jfo.2017.04.00716.Bielefeld P, Saadoun D, Héron E, et al. Scleritis and systemic diseases: What should know the internist? Rev Med Interne. 2018;39(9):711–720. DOI: 10.1016/j.revmed.2018.02.001 (In Fran.)Bielefeld P., Saadoun D., Héron E., et al. Sclérites et maladies systémiques: que doit savoir l’interniste? // Rev Med Interne. 2018. Vol. 39, No. 9. P. 711–720. DOI: 10.1016/j.revmed.2018.02.00117.Yoshida A, Watanabe M, Okubo A, Kawashima H. Clinical characteristics of scleritis patients with emphasized comparison of associated systemic diseases (anti-neutrophil cytoplasmic antibody-associated vasculitis and rheumatoid arthritis). Jpn J Ophthalmol. 2019;63(5):417–424. DOI: 10.1007/s10384-019-00674-7Yoshida A., Watanabe M., Okubo A., Kawashima H. Clinical characteristics of scleritis patients with emphasized comparison of associated systemic diseases (anti-neutrophil cytoplasmic antibody-associated vasculitis and rheumatoid arthritis) // Jpn J Ophthalmol. 2019. Vol. 63, No. 5. P. 417–424. DOI: 10.1007/s10384-019-00674-718.Nevares A, Raut R, Libman B, Hajj-Ali R. Noninfectious Autoimmune Scleritis: Recognition, Systemic Associations, and Therapy. Curr Rheumatol Rep. 2020;22(4):11. DOI: 10.1007/s11926-020-0885-yNevares A., Raut R., Libman B., Hajj-Ali R. Noninfectious Autoimmune Scleritis: Recognition, Systemic Associations, and Therapy // Curr Rheumatol Rep. 2020. Vol. 22, No. 4. P. 11. DOI: 10.1007/s11926-020-0885-y19.Clavel G, Gabison E, Semerano L. Corneal and scleral involvement in inflammatory rheumatic disease: Rheumatologists and ophthalmologists exchanging views. Joint Bone Spine. 2019;86(6):699–705. DOI: 10.1016/j.jbspin.2019.01.014Clavel G., Gabison E., Semerano L. Corneal and scleral involvement in inflammatory rheumatic disease: Rheumatologists and ophthalmologists exchanging views // Joint Bone Spine. 2019. Vol. 86, No. 6. P. 699–705. DOI: 10.1016/j.jbspin.2019.01.01420.Szepessy Z, Barsi Á, Kránitz K, Nagy ZZ. The Evolution of Central Retinal and Choroidal Thickness in Acute Anterior Uveitic Patients with Spondyloarthropathy. J Ophthalmol. 2018;2018:9136017. DOI: 10.1155/2018/9136017Szepessy Z., Barsi Á., Kránitz K., Nagy Z.Z. The Evolution of Central Retinal and Choroidal Thickness in Acute Anterior Uveitic Patients with Spondyloarthropathy // J Ophthalmol. 2018. Vol. 2018. P. 9136017. DOI: 10.1155/2018/913601721.Ferreira CS, Beato J, Falcão MS, et al. Choroidal thickness in multisystemic autoimmune diseases without ophthalmologic manifestations. Retina. 2017;37(3):529–535. DOI: 10.1097/IAE.0000000000001193Ferreira C.S., Beato J., Falcão M.S., et al. Choroidal thickness in multisystemic autoimmune diseases without ophthalmologic manifestations // Retina. 2017. Vol. 37, No. 3. P. 529–535. DOI: 10.1097/IAE.000000000000119322.Tetikoglu M, Temizturk F, Sagdik HM, et al. Evaluation of the Choroid, Fovea, and Retinal Nerve Fiber Layer in Patients with Rheumatoid Arthritis. Ocul Immunol Inflamm. 2017;25(2):210–214. DOI: 10.3109/09273948.2015.1095303Tetikoglu M., Temizturk F., Sagdik H.M., et al. Evaluation of the Choroid, Fovea, and Retinal Nerve Fiber Layer in Patients with Rheumatoid Arthritis // Ocul Immunol Inflamm. 2017. Vol. 25, No. 2. P. 210–214. DOI: 10.3109/09273948.2015.109530323.Kurt A, Kurt EE, Kilic R, et al. Is choroidal thickness related with disease activity and joint damage in patient with rheumatoid arthritis. Bratisl Lek Listy. 2017;118(1):23–27. DOI: 10.4149/BLL_2017_005Kurt A., Kurt E.E., Kilic R., et al. Is choroidal thickness related with disease activity and joint damage in patient with rheumatoid arthritis // Bratisl Lek Listy. 2017. Vol. 118, No. 1. P. 23–27. DOI: 10.4149/BLL_2017_00524.Ten Berge JC, Schreurs MWJ, van Daele PLA, Rothova A. Autoimmunity in uveitis. Acta Ophthalmol. 2018;96(5):481–485. DOI: 10.1111/aos.13652Ten Berge J.C., Schreurs M.W.J., van Daele P.L.A., Rothova A. Autoimmunity in uveitis // Acta Ophthalmol. 2018. Vol. 96, No. 5. P. 481–485. DOI: 10.1111/aos.1365225.D’Ambrosio EM, La Cava M, Tortorella P, et al. Clinical Features and Complications of the HLA-B27-associated Acute Anterior Uveitis: A Metanalysis. Semin Ophthalmol. 2017;32(6):689–701. DOI: 10.3109/08820538.2016.1170158D’Ambrosio E.M., La Cava M., Tortorella P., et al. Clinical Features and Complications of the HLA-B27-associated Acute Anterior Uveitis: A Metanalysis // Semin Ophthalmol. 2017. Vol. 32, No. 6. P. 689–701. DOI: 10.3109/08820538.2016.117015826.Barut K, Adrovic A, Şahin S, Kasapçopur Ö. Juvenile Idiopathic Arthritis. Balkan Med J. 2017;34(2):90–101. DOI: 10.4274/balkanmedj.2017.0111Barut K., Adrovic A., Şahin S., Kasapçopur Ö. Juvenile Idiopathic Arthritis // Balkan Med J. 2017. Vol. 34, No. 2. P. 90–101. DOI: 10.4274/balkanmedj.2017.011127.Hayworth JL, Turk MA, Nevskaya T, Pope JE. The frequency of uveitis in patients with juvenile inflammatory rheumatic diseases. Joint Bone Spine. 2019;86(6):685–690. DOI: 10.1016/j.jbspin.2019.06.001Hayworth J.L., Turk M.A., Nevskaya T., Pope J.E. The frequency of uveitis in patients with juvenile inflammatory rheumatic diseases // Joint Bone Spine. 2019. Vol. 86, No. 6. P. 685–690. DOI: 10.1016/j.jbspin.2019.06.00128.Celis R, Cuervo A, Ramírez J, Cañete JD. Psoriatic Synovitis: Singularity and Potential Clinical Implications. Front Med (Lausanne). 2019;6:14. DOI: 10.3389/fmed.2019.00014Celis R., Cuervo A., Ramírez J., Cañete J.D. Psoriatic Synovitis: Singularity and Potential Clinical Implications // Front Med (Lausanne). 2019. Vol. 6. P. 14. DOI: 10.3389/fmed.2019.0001429.Cantini F, Niccoli L, Nannini C, et al. Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Semin Arthritis Rheum. 2017;47(2):183–192. DOI: 10.1016/j.semarthrit.2017.03.008Cantini F., Niccoli L., Nannini C., et al. Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis // Semin Arthritis Rheum. 2017. Vol. 47, No. 2. P. 183–192. DOI: 10.1016/j.semarthrit.2017.03.00830.Duica I, Voinea LM, Mitulescu C, et al. The use of biologic therapies in uveitis. Rom J Ophthalmol. 2018;62(2):105–113.Duica I., Voinea L.M., Mitulescu C., et al. The use of biologic therapies in uveitis // Rom J Ophthalmol. 2018. Vol. 62, No. 2. P. 105–113.31.Turk MA, Hayworth JL, Nevskaya T, Pope JE. Ocular manifestations in rheumatoid arthritis, connective tissue disease and vasculitis: a systematic review and meta-analysis. [published online ahead of print, 2020 May 1] J Rheumatol. 2021:48(1):25–34. DOI: 10.3899/jrheum.190768Turk M.A., Hayworth J.L., Nevskaya T., Pope J.E. Ocular manifestations in rheumatoid arthritis, connective tissue disease and vasculitis: a systematic review and meta-analysis [published online ahead of print, 2020 May 1] // J Rheumatol. 2021. Vol. 48, No. 1. P. 25–34. DOI: 10.3899/jrheum.19076832.Accorinti M, Okada AA, Smith JR, Gilardi M. Epidemiology of Macular Edema in Uveitis. Ocul Immunol Inflamm. 2019;27(2): 169–180. DOI: 10.1080/09273948.2019.1576910Accorinti M., Okada A.A., Smith J.R., Gilardi M. Epidemiology of Macular Edema in Uveitis // Ocul Immunol Inflamm. 2019. Vol. 27, No. 2. P. 169–180. DOI: 10.1080/09273948.2019.157691033.Aydin E, Atik S, Koc F, et al. Choroidal and central foveal thickness in patients with scleroderma and its systemic associations. Clin Exp Optom. 2017;100(6):656–662. DOI: 10.1111/cxo.12498Aydin E., Atik S., Koc F., et al. Choroidal and central foveal thickness in patients with scleroderma and its systemic associations // Clin Exp Optom. 2017. Vol. 100, No. 6. P. 656–662. DOI: 10.1111/cxo.1249834.Gascon P, Jarrot PA, Matonti F, Kaplanski G. Retinal vasculitis and systemic diseases. Rev Med Interne. 2018;39(9):721–727. DOI: 10.1016/j.revmed.2018.04.013Gascon P., Jarrot P.A., Matonti F., Kaplanski G. Vascularites rétiniennes et maladies systémiques // Rev Med Interne. 2018. Vol. 39, No. 9. P. 721–727. DOI: 10.1016/j.revmed.2018.04.01335.Häuser W, Fitzcharles MA. Facts and myths pertaining to fibromyalgia. Dialogues Clin Neurosci. 2018;20(1):53–62. DOI: 10.31887/DCNS.2018.20.1/whauserHäuser W, Fitzcharles MA. Facts and myths pertaining to fibromyalgia // Dialogues Clin Neurosci. 2018. Vol. 20, No. 1. P. 53–62. DOI: 10.31887/DCNS.2018.20.1/whauser36.Adiguzel S, Palamar M, Yargucu F, et al. Evaluation of Ocular Surface and Meibomian Glands in Patients With Scleroderma. Cornea. DOI: 10.1097/ICO.0000000000002551Adiguzel S., Palamar M., Yargucu F., et al. Evaluation of Ocular Surface and Meibomian Glands in Patients with Scleroderma // Cornea. DOI: 10.1097/ICO.000000000000255137.Szucs G, Szekanecz Z, Aszalos Z, et al. A Wide Spectrum of Ocular Manifestations Signify Patients with Systemic Sclerosis. Ocul Immunol Inflamm. 2021;29(1):81–89. DOI: 10.1080/09273948.2019.1657467Szucs G., Szekanecz Z., Aszalos Z., et al. A Wide Spectrum of Ocular Manifestations Signify Patients with Systemic Sclerosis // Ocul Immunol Inflamm. 2021. Vol. 29, No. 1. P. 81–89. DOI: 10.1080/09273948.2019.1657467